Inflammatory bowel diseases are autoimmune systemic forms of pathology. The concept of continuous life-long drug intake is a cornerstone in their therapy. The review presents the factors that reduce patients adherence to treatment and ways to improve it. They include informing the patient about the disease and treatment, selection of individual therapy regimen, consolidation of achievements, provision of social support and interaction with other specialists.
Keywords: Crohn's disease; adherence to therapy; compliance; inflammatory bowel disease; methods of measuring adherence; questionnaires; scales; ulcerative colitis.